ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: CTI BioPharma Corp. (CTIC) Report Updated: Aug 19, 2017 | Print This Page

Get more stock ratings by Louis Navellier

CTI BioPharma Corp. (CTIC)

Rating: Hold Volatility: Moderate
Total Grade: C Industry: Biotechnology
Competitors: CALA,EXEL,MDXG,KITE

Stock Analysis

Rating: Monthly View

A
B
C
D
F
August September October November December January February March April May June July

Rating: Weekly View

This Week: C down no change
Last Week: C same upgrade
Two Weeks Ago: D up no change
service keys

CTI BioPharma Corp.© quotemedia

Company Profile